People with behavioral health conditions such as serious mental illness (SMI) and substance use disorders (SUDs), including opioid use disorder (OUD), are 3-6 times more likely than the general population to be represented in the criminal justice system.
Office of Behavioral Health, Disability, and Aging Policy (BHDAP)
The Office of Behavioral Health, Disability, and Aging Policy (BHDAP) focuses on policies and programs that support the independence, productivity, health and well-being, and long-term care needs of people with disabilities, older adults, and people with mental and substance use disorders.
Note: BHDAP was previously known as the Office of Disability, Aging, and Long-Term Care Policy (DALTCP). Only our office name has changed, not our mission, portfolio, or policy focus.
The Division of Behavioral Health Policy is responsible for the analysis, coordination, research and evaluation of policies related to mental and substance use disorders, also referred to as behavioral health. The division is the focal point for policy development and analysis related to the financing, access/delivery, organization, and quality of services for people with mental and substance use disorders, including those supported or financed by Medicaid, Medicare, and the Substance Abuse and Mental Health Services Administration (SAMHSA).
The Division of Long-Term Services and Supports is responsible for the analysis, coordination, and research and evaluation of policies related to institutional and community-based long-term care and supportive services, including formal and informal caregiving. The Division is the focal point for policy development and analysis related to the financing, delivery, organization, and quality of long-term care services and supports, including those supported or financed by private insurers, Medicaid, Medicare, and the Administration for Community Living (ACL).
The Division of Disability and Aging Policy is responsible for policy and data development, coordination, research and evaluation of policies and programs focused on the functioning and well-being of persons with disabilities and older adults. The Division is the focal point for crosscutting disability and aging collaboration within the Department and across other federal agencies. Alzheimer’s disease and related dementias and intellectual and developmental disabilities, including Autism Spectrum Disorder, are notable areas of engagement and expertise.
Helpful Information:
Reports
Displaying 101 - 110 of 976. 10 per page. Page 11.
Advanced SearchSupport And Services at Home (SASH) Evaluation: Highlights from the Evaluation of Program Outcomes from 2010 to 2016
This paper describes the primary features of the SASH program and summarizes the main findings of the evaluation to date.
Support And Services at Home (SASH) Evaluation: SASH Evaluation Findings, 2010-2016
This document provides highlights of the evaluation of the Support and Services at Home (SASH) program for the first years of the program (2010-2016). The SASH program in Vermont is a promising approach to providing support services and care coordination to older adults and individuals with disabilities, using affordable housing properties as a platform for service delivery.
Report
Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions
The purpose of this report is to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.
Psychosocial Supports in Medication-Assisted Treatment: Recent Evidence and Current Practice
ABSTRACT
This report was included as Appendix B of "Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions." That report's purpose was to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.
ASPE Issue Brief
Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief
Westat Printer Friendly Version in PDF Format (3 PDF pages)
ASPE Issue Brief
Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief
As the opioid epidemic has evolved into a national crisis, the need for treatment has increased greatly. Medication-assisted treatment (MAT) is a “whole-patient” approach to the treatment of opioid use disorder (OUD) that combines the use of medications and psychosocial supports, such as therapy, counseling, self-help groups, and case management.
Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions
July 2019
Printer Friendly Version in PDF Format (47 PDF pages)
Choice Matters: Housing Models that May Promote Recovery for Individuals and Families Facing Opioid Use Disorder
The purpose of the Opioid Use Disorder, Housing Instability and Housing Options for Recovery project was to help ASPE and HUD describe the housing models available for individuals with Opioid Use Disorder (OUD) who experience housing instability or homelessness.
Choices Matter: Housing Models that May Promote Recovery for Individuals and Families Facing Opioid Use Disorder
ASPE recently completed a research project, conducted by Abt Associates, that explored homelessness and opioid use disorder, along with the evidence base for different models for care. This brief is highlights of findings from the project.